Transfection of tumor-infiltrating T cells with mRNA encoding CXCR2

Manja Idorn*, Eivind Per thor Straten, Inge Marie Svane, Özcan Met

*Corresponding author for this work
8 Citations (Scopus)

Abstract

Adoptive T-cell therapy based on the infusion of patient’s own immune cells after ex vivo culturing is among the most potent forms of personalized treatment among recent clinical developments for the treatment of cancer. However, despite high rates of successful initial clinical responses, only about 20 % of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes (TILs) enter complete and long-term regression, with the majority either relapsing after initial partial regression or not benefiting at all. Previous studies have shown a positive correlation between the number infused T cells migrating to the tumor and the clinical response, but also that only a small fraction of adoptively transferred Tcells reach the tumor site. In this chapter, we describe a protocol for transfection of TILs with mRNA encoding the chemokine receptor CXCR2 transiently redirecting and improving TILs migration toward tumor-secreted chemokines in vitro.

Original languageEnglish
Title of host publicationSynthetic mRNA : Production, Introduction Into Cells, and Physiological Consequences
EditorsRobert E. Rhoads
Number of pages16
Volume1428
PublisherSpringer
Publication date2016
Pages261-276
Chapter17
ISBN (Print)978-1-4939-3623-6
ISBN (Electronic)978-1-4939-3625-0
DOIs
Publication statusPublished - 2016
SeriesMethods in Molecular Biology
Volume1428
ISSN1064-3745

Keywords

  • Cancer immunotherapy
  • Chemokine receptor
  • mRNA transfection
  • Tumor homing
  • Tumor-infiltrating lymphocytes (TILs)

Fingerprint

Dive into the research topics of 'Transfection of tumor-infiltrating T cells with mRNA encoding CXCR2'. Together they form a unique fingerprint.

Cite this